Encepheal Therapeutics
DefunctYC S19Winston-Salem, US Β· Founded 2015 Β· 3 employees Β· 1 known investors
EncepHeal develops small-molecule medications targeting the dopamine transporter to treat stimulant addiction, including cocaine and methamphetamine, for which no FDA-approved treatments currently exist. The company uses allosteric modulators designed to reduce drug cravings without the addictive potential of earlier dopamine-targeting approaches.
Founders & leadershipΒ· Y Combinator alumni (S19)
Encepheal Therapeutics was founded in 2015 by Aaron Lazarus and Omeed Rahimi.
AL
Aaron LazarusinπCo Founder and Chief Executive Officer2015β2022Aaron Lazarus founded EncepHeal Therapeutics, a company developing medications for substance abuse treatment, and previously served as its CEO. He holds both undergraduate and graduate degrees from Wake Forest University.
OR
Omeed RahimiinFounder
Investors Β· 1
Non-dilutive funding Β· 2 SBIR/STTR awards
Federal grants β no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2020 | $339.6K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2017 | $454.2K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts β non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Encepheal Therapeutics do?
- EncepHeal develops small-molecule medications targeting the dopamine transporter to treat stimulant addiction, including cocaine and methamphetamine, for which no FDA-approved treatments currently exist. The company uses allosteric modulators designed to reduce drug cravings without the addictive potential of earlier dopamine-targeting approaches.
- Who founded Encepheal Therapeutics?
- Encepheal Therapeutics was founded by Aaron Lazarus, Omeed Rahimi in 2015.
- Who are Encepheal Therapeutics's investors?
- Encepheal Therapeutics's investors include Y Combinator.
- Where is Encepheal Therapeutics headquartered?
- Encepheal Therapeutics is headquartered in Winston-Salem, US.